Heiko S. Schadt

Drug-induced phospholipidosis confounds drug repurposing for SARS-CoV-2

Tia A. Tummino, Veronica V. Rezelj, Benoit Fischer et al. · Science · 2021 · 223 citations · Full text

Medicine, Infectious Diseases, Pharmacology +15

Discovery of Roblitinib (FGF401) as a Reversible-Covalent Inhibitor of the Kinase Activity of Fibroblast Growth Factor Receptor 4

Robin A. Fairhurst, Thomas Knoepfel, Nicole Buschmann et al. · Journal of Medicinal Chemistry · 2020 · 113 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

FGF401, A First-In-Class Highly Selective and Potent FGFR4 Inhibitor for the Treatment of FGF19-Driven Hepatocellular Cancer

Andreas Weiss, Flavia Adler, Alexandra Buhles et al. · Molecular Cancer Therapeutics · 2019 · 102 citations

Medicine, Oncology, Pharmacology +16

Novel insights into bile acid detoxification via CYP, UGT and SULT enzymes

Vlasia Kastrinou Lampou, Birk Poller, Felix Huth et al. · Toxicology in Vitro · 2022 · 33 citations

Life Sciences, Biochemistry, Pharmacology +12

Quantification of Vitamin D3 in Feed, Food, and Pharmaceuticals Using High-Performance Liquid Chromatography/Tandem Mass Spectrometry

Heiko S. Schadt, Richard Gössl, Natalie Seibel et al. · Journal of AOAC International · 2012 · 30 citations · Full text

Agriculture, Food Science, Nutritional Sciences +17